company background image

Insulet DB:GOV Stock Report

Last Price


Market Cap







12 Mar, 2023


Company Financials +

GOV Stock Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

GOV fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance1/6
Financial Health2/6

My Notes

Capture your thoughts, links and company narrative

Insulet Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Insulet
Historical stock prices
Current Share PriceUS$262.30
52 Week HighUS$313.45
52 Week LowUS$176.24
1 Month Change-4.60%
3 Month Change-7.93%
1 Year Change28.64%
3 Year Change82.15%
5 Year Change286.99%
Change since IPO2,190.83%

Recent News & Updates

Recent updates

Shareholder Returns

GOVDE Medical EquipmentDE Market

Return vs Industry: GOV exceeded the German Medical Equipment industry which returned -6% over the past year.

Return vs Market: GOV exceeded the German Market which returned -4.9% over the past year.

Price Volatility

Is GOV's price volatile compared to industry and market?
GOV volatility
GOV Average Weekly Movement3.5%
Medical Equipment Industry Average Movement4.5%
Market Average Movement5.0%
10% most volatile stocks in DE Market9.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: GOV is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: GOV's weekly volatility (4%) has been stable over the past year.

About the Company

20002,600Jim Hollingshead

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

Insulet Corporation Fundamentals Summary

How do Insulet's earnings and revenue compare to its market cap?
GOV fundamental statistics
Market Cap€18.32b
Earnings (TTM)€4.32m
Revenue (TTM)€1.23b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GOV income statement (TTM)
Cost of RevenueUS$499.70m
Gross ProfitUS$805.60m
Other ExpensesUS$801.00m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date


Earnings per share (EPS)0.066
Gross Margin61.72%
Net Profit Margin0.35%
Debt/Equity Ratio294.2%

How did GOV perform over the long term?

See historical performance and comparison